Back to Search Start Over

Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice

Authors :
Abraham, David
Hess, Jessica A.
Mejia, Rojelio
Nolan, Thomas J.
Lok, James B.
Lustigman, Sara
Nutman, Thomas B.
Source :
Vaccine. Oct2011, Vol. 29 Issue 45, p8134-8140. 7p.
Publication Year :
2011

Abstract

Abstract: Human intestinal infections with the nematode Strongyloides stercoralis remain a significant problem worldwide and a vaccine would be a useful addition to the tools available to prevent and control this infection. The goal of this study was to test single antigens for their efficacy in a vaccine against S. stercoralis larvae in mice. Alum was used as the adjuvant in these studies and antigens selected for analysis were either recognized by protective human IgG (Ss-TMY-1, Ss-EAT-6, and Ss-LEC-5) or were known to be highly immunogenic in humans (Ss-NIE-1 and Ss-IR). Only mice immunized with the Ss-IR antigen demonstrated a significant decrease of approximately 80% in the survival of larval parasites in the challenge infection. Antibodies, recovered from mice with protective immunity to S. stercoralis after immunization with Ss-IR, were used to locate the antigen in the larvae. Confocal microscopy revealed that IgG from mice immunized with Ss-IR bound to the surface of the parasites and observations by electron microscopy indicated that IgG bound to granules in the glandular esophagus. Serum collected from mice immunized with Ss-IR passively transferred immunity to naïve mice. These studies demonstrate that Ss-IR, in combination with alum, induces high levels of protective immunity through an antibody dependent mechanism and may therefore be suitable for further development as a vaccine against human strongyloidiasis. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
0264410X
Volume :
29
Issue :
45
Database :
Academic Search Index
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
66411264
Full Text :
https://doi.org/10.1016/j.vaccine.2011.08.030